• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实验性糖尿病通过一种涉及酪氨酸硝化以及血管内皮生长因子和尿激酶型纤溶酶原激活剂受体表达增加的机制,导致血视网膜屏障破坏。

Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor.

作者信息

El-Remessy Azza B, Behzadian M Ali, Abou-Mohamed Gamal, Franklin Telina, Caldwell Robert W, Caldwell Ruth B

机构信息

Vascular Biology Center, Medical College of Georgia, Augusta, Georgia 30909, USA.

出版信息

Am J Pathol. 2003 Jun;162(6):1995-2004. doi: 10.1016/S0002-9440(10)64332-5.

DOI:10.1016/S0002-9440(10)64332-5
PMID:12759255
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1868147/
Abstract

The purpose of these experiments was to determine the specific role of reactive oxygen species (ROS) in the blood-retinal barrier (BRB) breakdown that characterizes the early stages of vascular dysfunction in diabetes. Based on our data showing that high glucose increases nitric oxide, superoxide, and nitrotyrosine formation in retinal endothelial cells, we hypothesized that excess formation of ROS causes BRB breakdown in diabetes. Because ROS are known to induce increases in expression of the well-known endothelial mitogen and permeability factor vascular endothelial growth factor (VEGF) we also examined their influence on the expression of VEGF and its downstream target urokinase plasminogen activator receptor (uPAR). After 2 weeks of streptozotocin-induced diabetes, analysis of albumin leakage confirmed a prominent breakdown of the BRB. This permeability defect was correlated with significant increases in the formation of nitric oxide, lipid peroxides, and the peroxynitrite biomarker nitrotyrosine as well as with increases in the expression of VEGF and uPAR. Treatment with a nitric oxide synthase inhibitor (N-omega-nitro-L-arginine methyl ester, 50 mg/kg/day) or peroxynitrite scavenger (uric acid, 160 mg/kg/day) blocked the breakdown in the BRB and prevented the increases in formation of lipid peroxides and tyrosine nitration as well as the increases in expression of VEGF and uPAR. Taken together, these data indicate that early diabetes causes breakdown of the BRB by a mechanism involving the action of reactive nitrogen species in promoting expression of VEGF and uPAR.

摘要

这些实验的目的是确定活性氧(ROS)在血视网膜屏障(BRB)破坏中所起的具体作用,BRB破坏是糖尿病血管功能障碍早期阶段的特征。基于我们的数据显示高糖会增加视网膜内皮细胞中一氧化氮、超氧化物和硝基酪氨酸的形成,我们推测ROS的过量形成会导致糖尿病中BRB的破坏。由于已知ROS会诱导著名的内皮细胞有丝分裂原和通透性因子血管内皮生长因子(VEGF)的表达增加,我们还研究了它们对VEGF及其下游靶点尿激酶型纤溶酶原激活剂受体(uPAR)表达的影响。在链脲佐菌素诱导的糖尿病2周后,白蛋白渗漏分析证实了BRB的显著破坏。这种通透性缺陷与一氧化氮、脂质过氧化物和过氧亚硝酸盐生物标志物硝基酪氨酸的形成显著增加以及VEGF和uPAR的表达增加相关。用一氧化氮合酶抑制剂(N-ω-硝基-L-精氨酸甲酯,50 mg/kg/天)或过氧亚硝酸盐清除剂(尿酸,160 mg/kg/天)治疗可阻断BRB的破坏,并防止脂质过氧化物形成和酪氨酸硝化增加以及VEGF和uPAR表达增加。综上所述,这些数据表明早期糖尿病通过一种涉及活性氮物质促进VEGF和uPAR表达的机制导致BRB的破坏。

相似文献

1
Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor.实验性糖尿病通过一种涉及酪氨酸硝化以及血管内皮生长因子和尿激酶型纤溶酶原激活剂受体表达增加的机制,导致血视网膜屏障破坏。
Am J Pathol. 2003 Jun;162(6):1995-2004. doi: 10.1016/S0002-9440(10)64332-5.
2
Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo.视网膜血管内皮生长因子诱导细胞间黏附分子-1和内皮型一氧化氮合酶表达,并在体内引发早期糖尿病视网膜白细胞黏附。
Am J Pathol. 2002 Feb;160(2):501-9. doi: 10.1016/S0002-9440(10)64869-9.
3
Diabetes-induced superoxide anion and breakdown of the blood-retinal barrier: role of the VEGF/uPAR pathway.糖尿病引起的超氧阴离子和血视网膜屏障的破坏:VEGF/uPAR 通路的作用。
PLoS One. 2013 Aug 7;8(8):e71868. doi: 10.1371/journal.pone.0071868. eCollection 2013.
4
Significance of nitric oxide and peroxynitrite in permeability changes of the retinal microvascular endothelial cell monolayer induced by vascular endothelial growth factor.一氧化氮和过氧亚硝酸盐在血管内皮生长因子诱导的视网膜微血管内皮细胞单层通透性变化中的意义
J Vasc Res. 1999 Nov-Dec;36(6):510-5. doi: 10.1159/000025694.
5
The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas.糖尿病大鼠视网膜中血管内皮生长因子表达与血视网膜屏障破坏之间的关系。
Lab Invest. 1996 Apr;74(4):819-25.
6
Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model.塞来昔布是一种选择性环氧化酶-2抑制剂,在链脲佐菌素诱导的糖尿病大鼠模型中,它可抑制视网膜血管内皮生长因子的表达及血管渗漏。
Eur J Pharmacol. 2003 Jan 5;458(3):283-9. doi: 10.1016/s0014-2999(02)02793-0.
7
VEGF164 is proinflammatory in the diabetic retina.血管内皮生长因子164(VEGF164)在糖尿病视网膜中具有促炎作用。
Invest Ophthalmol Vis Sci. 2003 May;44(5):2155-62. doi: 10.1167/iovs.02-0807.
8
High glucose-induced tyrosine nitration in endothelial cells: role of eNOS uncoupling and aldose reductase activation.高糖诱导内皮细胞酪氨酸硝化:内皮型一氧化氮合酶解偶联和醛糖还原酶激活的作用
Invest Ophthalmol Vis Sci. 2003 Jul;44(7):3135-43. doi: 10.1167/iovs.02-1022.
9
Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF.急性强化胰岛素治疗通过缺氧诱导因子-1α和血管内皮生长因子加剧糖尿病性血视网膜屏障破坏。
J Clin Invest. 2002 Mar;109(6):805-15. doi: 10.1172/JCI13776.
10
Short-term insulin treatment and aortic expressions of IGF-1 receptor and VEGF mRNA in diabetic rats.短期胰岛素治疗与糖尿病大鼠主动脉中IGF-1受体及VEGF mRNA的表达
Am J Physiol Heart Circ Physiol. 2002 Nov;283(5):H1761-8. doi: 10.1152/ajpheart.00248.2002.

引用本文的文献

1
Endothelial function can be modulated by acute hyperglycemia.内皮功能可被急性高血糖所调节。
Sci Rep. 2025 Aug 20;15(1):30559. doi: 10.1038/s41598-025-12612-4.
2
Oral Intake of Hydrogen Water Improves Retinal Blood Flow Dysregulation in Response to Flicker Stimulation and Systemic Hyperoxia in Diabetic Mice.口服氢气水可改善糖尿病小鼠对闪烁刺激和全身高氧的视网膜血流调节障碍。
Transl Vis Sci Technol. 2024 Oct 1;13(10):36. doi: 10.1167/tvst.13.10.36.
3
High Glucose Increases Lactate and Induces the Transforming Growth Factor Beta-Smad 1/5 Atherogenic Pathway in Primary Human Macrophages.高糖增加乳酸生成并诱导原代人巨噬细胞中转化生长因子β-Smad 1/5致动脉粥样硬化信号通路。
Biomedicines. 2024 Jul 16;12(7):1575. doi: 10.3390/biomedicines12071575.
4
Effects of Nox4 upregulation on PECAM-1 expression in a mouse model of diabetic retinopathy.Nox4 上调对糖尿病视网膜病变小鼠模型中 PECAM-1 表达的影响。
PLoS One. 2024 May 15;19(5):e0303010. doi: 10.1371/journal.pone.0303010. eCollection 2024.
5
Investigation of the Effects of a Novel NOX2 Inhibitor, GLX7013170, against Glutamate Excitotoxicity and Diabetes Insults in the Retina.新型NOX2抑制剂GLX7013170对视网膜谷氨酸兴奋性毒性和糖尿病损伤影响的研究
Pharmaceuticals (Basel). 2024 Mar 19;17(3):393. doi: 10.3390/ph17030393.
6
C1q/TNF-Related Protein 3 Prevents Diabetic Retinopathy via AMPK-Dependent Stabilization of Blood-Retinal Barrier Tight Junctions.C1q/TNF 相关蛋白 3 通过 AMPK 依赖途径稳定血视网膜屏障紧密连接来预防糖尿病视网膜病变。
Cells. 2022 Feb 23;11(5):779. doi: 10.3390/cells11050779.
7
Wnt Signaling in Inner Blood-Retinal Barrier Maintenance.Wnt 信号在维持内血液视网膜屏障中的作用。
Int J Mol Sci. 2021 Nov 2;22(21):11877. doi: 10.3390/ijms222111877.
8
The stress response protein REDD1 as a causal factor for oxidative stress in diabetic retinopathy.应激反应蛋白 REDD1 作为糖尿病性视网膜病变中氧化应激的一个因果因素。
Free Radic Biol Med. 2021 Mar;165:127-136. doi: 10.1016/j.freeradbiomed.2021.01.041. Epub 2021 Jan 29.
9
Tangeretin Inhibition of High-Glucose-Induced IL-1, IL-6, TGF-1, and VEGF Expression in Human RPE Cells.蜜橘黄素抑制人 RPE 细胞高糖诱导的 IL-1、IL-6、TGF-β1 和 VEGF 表达。
J Diabetes Res. 2020 Dec 7;2020:9490642. doi: 10.1155/2020/9490642. eCollection 2020.
10
Global assessment of arteriolar, venular and capillary changes in normal tension glaucoma.正常眼压性青光眼中小动脉、小静脉和毛细血管变化的全球评估。
Sci Rep. 2020 Nov 5;10(1):19222. doi: 10.1038/s41598-020-75784-1.

本文引用的文献

1
High glucose-induced tyrosine nitration in endothelial cells: role of eNOS uncoupling and aldose reductase activation.高糖诱导内皮细胞酪氨酸硝化:内皮型一氧化氮合酶解偶联和醛糖还原酶激活的作用
Invest Ophthalmol Vis Sci. 2003 Jul;44(7):3135-43. doi: 10.1167/iovs.02-1022.
2
VEGF-induced paracellular permeability in cultured endothelial cells involves urokinase and its receptor.血管内皮生长因子诱导培养的内皮细胞的细胞旁通透性涉及尿激酶及其受体。
FASEB J. 2003 Apr;17(6):752-4. doi: 10.1096/fj.02-0484fje. Epub 2003 Feb 19.
3
Suppression of diabetic retinopathy with angiopoietin-1.血管生成素-1对糖尿病性视网膜病变的抑制作用
Am J Pathol. 2002 May;160(5):1683-93. doi: 10.1016/S0002-9440(10)61115-7.
4
Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite.锌硫醇盐复合物的氧化及过氧亚硝酸盐对内皮型一氧化氮合酶的解偶联作用。
J Clin Invest. 2002 Mar;109(6):817-26. doi: 10.1172/JCI14442.
5
Induction of vascular endothelial growth factor expression and hypoxia-inducible factor 1alpha protein by the oxidative stressor arsenite.氧化应激源亚砷酸盐诱导血管内皮生长因子表达及缺氧诱导因子1α蛋白产生。
J Biol Chem. 2001 Dec 21;276(51):48066-76. doi: 10.1074/jbc.M106282200. Epub 2001 Oct 18.
6
VEGF-initiated blood-retinal barrier breakdown in early diabetes.糖尿病早期血管内皮生长因子引发的血视网膜屏障破坏
Invest Ophthalmol Vis Sci. 2001 Sep;42(10):2408-13.
7
Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress.糖尿病血浆中硝基酪氨酸的检测:氧化应激的证据。
Diabetologia. 2001 Jul;44(7):834-8. doi: 10.1007/s001250100529.
8
Constitutive nitric oxide synthase is associated with retinal vascular permeability in early diabetic rats.组成型一氧化氮合酶与早期糖尿病大鼠的视网膜血管通透性有关。
Diabetologia. 2001 Aug;44(8):1043-50. doi: 10.1007/s001250100588.
9
Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: Role of the p22(phox)-containing NADPH oxidase.凝血酶激活血管平滑肌细胞中的缺氧诱导因子-1信号通路:含p22(phox)的NADPH氧化酶的作用。
Circ Res. 2001 Jul 6;89(1):47-54. doi: 10.1161/hh1301.092678.
10
Nitration and oxidation of a hydrophobic tyrosine probe by peroxynitrite in membranes: comparison with nitration and oxidation of tyrosine by peroxynitrite in aqueous solution.过氧亚硝酸根对膜中疏水性酪氨酸探针的硝化和氧化作用:与过氧亚硝酸根在水溶液中对酪氨酸的硝化和氧化作用的比较。
Biochemistry. 2001 Jun 26;40(25):7675-86. doi: 10.1021/bi002958c.